193
ViiV Healthcare, a GlaxoSmithKline-majority global HIV company ranks first in PatientView’s “Corporate Reputation of Pharma – from the Patient Perspective 2020-2021” global survey for the eighth consecutive year. “The Covid-19 pandemic has made 2020 a year characterized by unique challenges around the world, not only for healthcare but also for the HIV community. However, in the face of a global crisis of this magnitude, which has profoundly impacted on the health and life of people, at ViiV Healthcare we have continued to commit ourselves to our mission: to ensure that no one with HIV is left behind, “reads a statement.